About Us

Mission / Vision

We are a Service-Disabled Veteran Owned business founded on the principle of harnessing data to heal the world. Our founders and executive team have a combined 75+ years of experience as industry leaders in artificial intelligence, machine learning and genomics.

Our flagship application, Curo46^TM is a personalized medicine SaaS platform that integrates extensive global health data with Electronic Medical Records (EMR), HIPAA compliant API’s and others. Curo46^TM provides predictive health risk management that decreases hospital readmissions, streamlines patient care, reduces costs and improves overall outcomes. We have assembled a world-class medical advisory board comprised of esteemed physicians and other healthcare leaders.

What do we do?

We create

Structure for unstructured data
Data curation for cluster formation to enable AI & Machine Learning
CNN’s at scale to enable precision healthcare/medicine

Why do we do it?

We help physicians and healthcare professionals to

Perceive disease before/after it occurs
Speed up decision making by aiding in treatment choices
Make pattern recognition easier to see over time (longitudinally)
Make medicine precise and individualized
Data curation for cluster formation to enable AI & Machine Learning
CNN’s at scale to enable precision healthcare/medicine

A fully integrated, customized solution for healthcare.

Government & Military Agencies Value Proposition

Data lakes (merge files, EMR records, data fabric)
Dispersion models
Re-admission risk analysis for hospitals (military and civilian)
Actionable alerts for disease risks
Anomaly detection, symptom tracking, and depression tracking

Healthcare Providers, Payers, Pharma/ Diagnostics Value Proposition

Heart disease prediction based on biomarkers, imaging & genetic information
Personalized treatment plans
Biomarkers discovery (machine learning helps identify new biomarkers for diseases crucial for diagnosis and monitoring treatments)
Predictive analytics for patient care (i.e. predict adverse events like falls, infections/sepsis, or health deterioration)
Operational efficiency – AI optimizes scheduling for staff & resource allocation

AJ Rosenthal

President & CEO

AJ brings over twenty years of experience in engineering and business development to General Genomics. He is a multi-disciplinary product innovator and entrepreneur, with a track record of successfully bringing new products to a global market.

He is a decorated combat veteran who served as a Navy Nuclear Engineer for eight years, with multiple wartime tours in the Persian Gulf. He holds a BS in Nuclear Engineering Technologies, an MBA in Finance, and a Graduate Certificate in Leadership.